Research Archives - VisionGate

September 9, 2023

VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Achieves High Sensitivity in Detecting Both Squamous Cell Carcinoma and Adenocarcinoma
More Information
Research
September 9, 2023

VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Detects True Abnormal Cells in Non-cancer Patients with Near 100% Specificity
More Information
Research
August 6, 2022

VisionGate Presents at the World Conference on Lung Cancer for 2022 in Vienna: New Assay for Smoking Status Based on 3D Imaging of Pulmonary Macrophages
More Information
Research
September 8, 2021

VisionGate Presents at the World Conference on Lung Cancer for 2021: Non-Intrusive LuCED® Test for Detection of Early-Stage Lung Cancer: Subgroup Analysis for Patients with Chronic Obstructive Pulmonary Disease (COPD)
More Information
Research
January 28, 2021

VisionGate Presents at the World Conference on Lung Cancer for 2020: LuCED® Sputum Test for Assessment of Lung Cancer Risk in COPD Patients: Sensitivity and Specimen Satisfactory Rate
More Information
Research
September 28, 2018

VisionGate Presents at the 2018 conference of the American Thoracic Society: Positive Rate Of The Lung Cell Evaluation (LuCED) Test For Patients With Chronic Obstructive Pulmonary Disease (COPD)
More Information
Research
September 28, 2018

VisionGate Presents at the World Conference on Lung Cancer for 2018 in Toronto: Malignancy Associated Change and The LuCED® Test for Detection of Early Stage Lung Cancer
More Information
Research
October 16, 2017

VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Effect of Tumor Size on the Sensitivity of the Non-Invasive LuCED® Test for Lung Cancer
More Information
Research
October 16, 2017

VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Morphometric Genotyping Identifies Lung Cancer Cells Harboring Target Mutations; Cell-CT® Platform Detects Gene Abnormalities
More Information
Research
October 16, 2017

VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Cell-CT® Differential Detection of Dysplastic Bronchial Epithelial Cells from Patient Explants
More Information
Research
December 5, 2016

VisionGate Presents at the World Conference on Lung Cancer for 2016 in Vienna: The Non-Invasive LuCED® test for Detection of Early Stage Lung Cancer
More Information
Research
December 5, 2016

VisionGate Presents at the World Conference on Lung Cancer for 2016 in Vienna: Non-Invasive LuCED® Test for Endobronchial Dysplasia, Enabling Chemoprevention Therapy with Drugs Such as Iloprost
More Information
Research
September 16, 2015

VisionGate Presents at the 2015 Conference of the American Society of Pathologists: Three Dimensional Cytologic Examination: Performance of the Cytopathologist Review Using CellGazer in the LuCED® Test for Lung Cancer Screening
More Information
Research
September 11, 2015

VisionGate Presents at the World Conference on Lung Cancer for 2015 in Denver:Blinded Clinical Study of the LuCED® Test for Detection of Early Stage Lung Cancer
More Information
Research
November 20, 2014

VisionGate Presents at the 2014 Conferene of the American Society of Pathologists: Lung Cancer Detection with LuCED, a Novel Test Based on 3D Cytometry of Sputum Cells
More Information
Research
May 15, 2014

VisionGate Presents at the 2014 conference of the American Society for Clinical Oncologists: Early detection of lung cancer based on three-dimensional, morphometric analysis of cells from sputum
More Information
Research
October 28, 2013

VisionGate presents at the 2013 World Conference on Lung Cancer in Sydney
More Information
Research
June 1, 2012

VisionGate Presents at the 2012 conference of the American Society for Clinical Oncologists:Early detection of lung cancer based on three-dimensional, morphometric analysis of cells from sputum following x-ray CT screening
More Information
Research
July 3, 2011

VisionGate Presents at the World Conference on Lung Cancer for 2011 in Amsterdam: The LuCED Test for Detection of Early Lung Cancer: A Criterion to Complete the Test with High Sensitivity
More Information
Research
July 31, 2009

VisionGate Presents at the World Conference on Lung Cancer for 2009 in San Francisco: The Lung Cell Evaluation Device (LuCED): Early Detection of Lung Cancer in Sputum Based on 3D Morphology
More Information
Research